pubchem.ncbi.nlm.nih.gov
Abstract
A new use of a selected microorganism is disclosed. The invention relates to a method for treating and preventing Coronavirus (COVID-19) infection in humans by direct pulmonary administration of an effective amount of a selected microorganism to the humans. The microorganism will stimulate the localized lung immune system, and produce antimicrobial and antivirus substances against COVID-19 infection, which is a new strategy for treating and preventing current world-wide epidemic COVID-19 infection. This method is simple, cost effective and using a commercially available strain that can be used to treat and prevent COVID- 19 infection for large populations.
